No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 0.2x · 10Y median 0.2x · 38th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 24
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T14:25:41.215Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T14:25:41.215Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T14:25:41.215Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T14:25:41.215Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T14:25:41.215Z. Latest historical point 2026-10-05.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T14:25:41.215Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T14:25:41.215Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T14:25:41.215Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for The Beachbody Company, Inc. (BODI) stock was $4.83 as of Oct 6, 2026, 10:16 AM EDT, up 0.21% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -17.4% · 3-year avg -34.3%/yr · 5-year avg -55.5%/yr
The Beachbody Co., Inc. operates as a health and wellness company.
Internet Content & Information · El Segundo, CA
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Next Earnings Date
Nov 9, 2026
34 days away
EPS Estimate
-0.18
Revenue Est.
$46.26M
Last Quarter Results
EPS
$0.18
vs Estimate
$-0.21
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1BODI | $34.98M | $4.83 | +0.21% | -17.39% | -55.45% | N/A | N/A |
| 2GAIA | $35.02M | $1.40 | +0.00% | -75.49% | -31.83% | -15.12% | vs BODI |
| 3ANGH | $33.54M | $3.70 | -0.69% | +24.62% | -48.29% | N/A | vs BODI |
| 4LVO | $30.04M | $2.73 | +3.21% | -38.09% | -38.74% | N/A | vs BODI |
| 5MNY | $29.97M | $0.68 | +1.47% | -53.94% | N/A | N/A | vs BODI |
| 6IZEA | $43.26M | $2.47 | +1.65% | -36.74% | -20.48% | -19.92% | vs BODI |
0.94
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$49.60M
vs Estimate
$49.30M
Consensus Rating
Based on 4 analysts
Average Price Target
$17.00
+252.0% upside
Low
$9.00
Current
$4.83
High
$22.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.23 | $-0.20 | $-0.18 | 3 |
| Quarter ending Dec 2026 | $-0.44 | $-0.16 | $0.06 | 3 |
| Quarter ending Mar 2027 | $-0.13 | $-0.13 | $-0.11 | 1 |
| Quarter ending Jun 2027 | $-0.16 | $-0.15 | $-0.14 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $0.10 | $0.11 | $0.13 | 2 |
| FY 2027 | $-3.51 | $0.09 | $4.86 | 3 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $45.93M | $46.26M | $46.83M | 4 |
| Quarter ending Dec 2026 | $44.04M | $47.43M | $49.88M | 4 |
| Quarter ending Mar 2027 | $44.16M | $47.75M | $50.28M | 2 |
| Quarter ending Jun 2027 | $44.81M | $48.45M | $51.01M | 2 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Dec 31, 2026, matching Key Metrics.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $193.87M | $197.58M | $199.78M | 4 |
| FY 2027 | $171.73M | $221.48M | $271.69M | 4 |
